Vaccination with Newcastle disease virus vectored vaccine protects chickens against highly pathogenic H7 avian influenza virus;La inmunización con una vacuna que contiene al virus de la enfermedad de Newcastle como vector protege a pollos contra un virus de la influenza aviar altamente patógeno subtipo H7

Avian Diseases

Volumn 53, Issue 2, 2009, Pages 190-197

  Schröer, Diana ^a   Veits, Jutta ^a   Grund, Christian ^a   Dauber, Malte ^a   Keil, Günther ^a   Granzow, Harald ^a   Mettenleiter, Thomas C ^a   Römer Oberdörfer, Angela ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

Avian influenza; H7N1; NDV; Vaccine

Indexed keywords

INFLUENZA VACCINE; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; VIRUS HEMAGGLUTININ;

ANIMAL; ARTICLE; AVIAN INFLUENZA; CHICKEN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; GENETICS; GERMFREE ANIMAL; IMMUNOELECTRON MICROSCOPY; IMMUNOLOGY; INFLUENZA VIRUS A; METABOLISM; NEWCASTLE DISEASE PARAMYXOVIRUS; PATHOGENICITY; PHYSIOLOGY; VIROLOGY; VIRULENCE;

ANIMALS; CHICKENS; GENE EXPRESSION REGULATION, VIRAL; GENETIC ENGINEERING; HEMAGGLUTININS, VIRAL; INFLUENZA A VIRUS; INFLUENZA IN BIRDS; INFLUENZA VACCINES; MICROSCOPY, IMMUNOELECTRON; NEWCASTLE DISEASE VIRUS; RECOMBINANT PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; VACCINES, SYNTHETIC; VIRULENCE;

ANIMALIA; AVES; AVIAN INFLUENZA VIRUS; GALLUS GALLUS; NEWCASTLE DISEASE VIRUS; ORTHOMYXOVIRIDAE;

EID: 68149154739     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/8416-072308-Reg.1     Document Type: Article

References (32)

1. Arnold, B., M. Messerle, L. Jatsch, G. Kublbeck, and U. Koszinowski. Transgenic mice expressing a soluble foreign H-2 class I antigen are tolerant to allogeneic fragments presented by self class I but not to the whole membrane-bound alloantigen. Proc. Natl. Acad. Sci. U.S.A. 87:1762-1766. 1990.
2. Boyle, D. B., P. Selleck, and H. G. Heine. Vaccinating chickens against avian influenza with fowlpox recombinants expressing the H7 haemagglutinin. Aust. Vet. J. 78:44-48. 2000.
3. Buchholz, U. J., S. Finke, and K. K. Conzelmann. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J. Virol. 73:251-259. 1999.
4. Capua, I., and S. Marangon. The use of vaccination to combat multiple introductions of notifiable avian influenza viruses of the H5 and H7 subtypes between 2000 and 2006 in Italy. Vaccine 25:4987-4995. 2007.
5. CEC. Council directive 92/40/EEC introducing community measures for the control of avian influenza. Official Journal of the European Communities L 167:1-16. 1992.
6. CEC. Council directive 92/66/EEC introducing community measures for the control of Newcastle disease. Official Journal of the European Communities L 260:1-20. 1992.
7. Crawford, J., B. Wilkinson, A. Vosnesensky, G. Smith, M. Garcia, H. Stone, and M. L. Perdue. Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes. Vaccine 17:2265-2274. 1999.
8. Elbers, A. R., T. H. Fabri, T. S. de Vries, J. J. de Wit, A. Pijpers, and G. Koch. The highly pathogenic avian influenza A (H7N7) virus epidemic in the Netherlands in 2003-lessons learned from the first five outbreaks. Avian Dis. 48:691-705. 2004.
9. Elbers, A. R., B. Kamps, and G. Koch. Performance of gross lesions at postmortem for the detection of outbreaks during the avian influenza A virus (H7N7) epidemic in the Netherlands in 2003. Avian Pathol. 33:418-422. 2004.
10. Fauquet, C. M., and M. A. Mayo. Paramyxoviridae. In: 8th report of the International Committee on the Taxonomy of Viruses. C. M. Fauquet, M. A. Mayo, J. Maniloff, U. Desselberger, and L. A. Ball, eds. Elsevier Academic Press, San Diego, London. pp. 655-671. 2005.
11. Fouchier, R. A., P. M. Schneeberger, F. W. Rozendaal, J. M. Broekman, S. A. Kemink, V. Munster, T. Kuiken, G. F. Rimmelzwaan, M. Schutten, G. J. Van Doornum, G. Koch, A. Bosman, M. Koopmans, and A. D. Osterhaus. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc. Natl. Acad. Sci. U.S.A. 101:1356-1361. 2004.
12. Francis, J. R. T., and J. E. Salk. A simplified procedure for the concentration and purification of influenza virus. Science 96:499-500. 1942.
13. Ge, J., G. Deng, Z. Wen, G. Tian, Y. Wang, J. Shi, X. Wang, Y. Li, S. Hu, Y. Jiang, C. Yang, K. Yu, Z. Bu, and H. Chen. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J. Virol. 81:150-158. 2007.
14. Huang, Z., S. Elankumaran, A. Panda, and S. K. Samal. Recombinant Newcastle disease virus as a vaccine vector. Poult. Sci. 82:899-906. 2003.
15. Jungherr, E. L., E. E. Tyzzer, C. A. Brandley, and H. E. Moses. The comparative pathology of fowl plague and Newcastle disease. Am. J. Vet. Res. 7:250-288. 1946.
16. Luschow, D., O. Werner, T. C. Mettenleiter, and W. Fuchs. Protection of chickens from lethal avian influenza A virus infection by live-virus vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene. Vaccine 19:4249-4259. 2001.
17. Nakaya, T., J. Cros, M. S. Park, Y. Nakaya, H. Zheng, A. Sagrera, E. Villar, A. Garcia-Sastre, and P. Palese. Recombinant Newcastle disease virus as a vaccine vector. J. Virol. 75:11868-11873. 2001.
18. Park, M. S., J. Steel, A. Garcia-Sastre, D. Swayne, and P. Palese. Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc. Natl. Acad. Sci. U.S.A. 103:8203-8208. 2006.
19. Peters, J. H. Zellfusion zur Herstellung von monoklonalen Antikörpern der Maus. In: Monoklonale Antikörper, 2nd ed. J. H. Peters, and H. Baumgarten, eds. Springer Verlag Berlin, Heidelberg, New York. pp. 150-157. 1988.
20. Rapp, M., M. Messerle, B. Buhler, M. Tannheimer, G. M. Keil, and U. H. Koszinowski. Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus. J. Virol. 66:4399-4406. 1992.
21. Römer-Oberdörfer, A., E. Mundt, T. Mebatsion, U. J. Buchholz, and T. C. Mettenleiter. Generation of recombinant lentogenic Newcastle disease virus from cDNA. J. Gen. Virol. 80:2987-2995. 1999.
22. Römer-Oberdörfer, A., J. Veits, D. Helferich, and T. C. Mettenleiter. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus-based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus. Vaccine 26:2307-2313. 2008.
23. Römer-Oberdörfer, A., O. Werner, J. Veits, T. Mebatsion, and T. C. Mettenleiter. Contribution of the length of the HN protein and the sequence of the F protein cleavage site to Newcastle disease virus pathogenicity. J. Gen. Virol. 84:3121-3129. 2003.
24. Suarez, D. L. Overview of avian influenza DIVA test strategies. Biologicals 33:221-226. 2005.
25. Swayne, D. E., M. Garcia, J. R. Beck, N. Kinney, and D. L. Suarez. Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert. Vaccine 18:1088-1095. 2000.
26. Swayne, D. E., D. L. Suarez, S. Schultz-Cherry, T. M. Tumpey, D. J. King, T. Nakaya, P. Palese, and A. Garcia-Sastre. Recombinant paramyxo-virus type 1-avian influenza-H7 virus as a vaccine for protection of chickens against influenza and Newcastle disease. Avian Dis. 47:1047-1050. 2003.
27. Taylor, J., and E. Paoletti. Fowlpox virus as a vector in non-avian species. Vaccine 6:466-468. 1988.
28. Tripathy, D. N., and W. M. Schnitzlein. Expression of avian influenza virus hemagglutinin by recombinant fowlpox virus. Avian Dis. 35:186-191. 1991.
29. Veits, J., D. Lüschow, K. Kindermann, O. Werner, J. P. Teifke, T. C. Mettenleiter, and W. Fuchs. Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague. J. Gen. Virol. 84:3343-3352. 2003.
30. Veits, J., D. Wiesner, W. Fuchs, B. Hoffmann, H. Granzow, E. Starick, E. Mundt, H. Schirrmeier, T. Mebatsion, T. C. Mettenleiter, and A. Römer-Oberdörfer. Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc. Natl. Acad. Sci. U.S.A. 103:8197-8202. 2006.
31. Webster, R. G., Y. Kawaoka, J. Taylor, R. Weinberg, and E. Paoletti. Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine 9:303-308. 1991.
32. Werner, O., A. Römer-Oberdörfer, B. Köllner, R. J. Manvell, and D. J. Alexander. Characterization of avian paramyxovirus type 1 strains isolated in Germany during 1992 to 1996. Avian Path. 28:79-88. 1999.